Equity Capital Markets

Company · CIK 1785530

Werewolf Therapeutics, Inc.

CIK1785530 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inDE
Business addressMA
ListedHOWL (Nasdaq)
First annual or quarterly report2021-06-10

Offerings

3 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-287078
ShelfEffective
 2025-05-082025-05-152
333-264844
ShelfEffective
 2022-05-102025-03-114
333-255132
IPOFinal prospectus
 2021-04-082021-04-304

Filings

11
FiledFilingRegistrationAccession
2025-05-15EFFECTDeclared effective 333-2870789999999995-25-001630
2025-05-08S-3Shelf registered 333-2870780001193125-25-115950
2025-03-11424B5Shelf takedown 333-2648440001193125-25-051439
2024-02-09424B5Shelf takedown 333-2648440001193125-24-030132
2022-05-20EFFECTDeclared effective 333-2648449999999995-22-001552
2022-05-10S-3Shelf registered 333-2648440001193125-22-146417
2021-04-30424B4Final prospectus 333-2551320001193125-21-145768
2021-04-29EFFECTDeclared effective 333-2551329999999995-21-001630
2021-04-26S-1/AAmendment 333-2551320001193125-21-130127
2021-04-08S-1Registration filed 333-2551320001193125-21-110310
2021-02-26DRSDraft made public 377-043220000950123-21-003178

All filings of this company · CSV